Immediate Impact
64 standout
Citing Papers
Acute kidney injury
2025 Standout
Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2025 Standout
Works of Dinesh K. Chatoth being referenced
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
2024
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dinesh K. Chatoth | 298 | 27 | 82 | 62 | 14 | 335 | |
| M Manns | 181 | 17 | 76 | 49 | 16 | 272 | |
| Amelia Sánchez | 127 | 21 | 67 | 48 | 23 | 313 | |
| P. D. Brophy | 277 | 49 | 78 | 54 | 10 | 336 | |
| Kera E. Luckritz | 158 | 13 | 48 | 53 | 10 | 262 | |
| Rajeev A Annigeri | 177 | 74 | 54 | 18 | 22 | 297 | |
| Timothy Kudelka | 164 | 25 | 52 | 77 | 10 | 309 | |
| Darren W. Schmidt | 207 | 23 | 120 | 38 | 25 | 367 | |
| P. E. Stevens | 177 | 17 | 102 | 19 | 20 | 336 | |
| A. B. Williams | 150 | 7 | 95 | 82 | 10 | 324 | |
| Srijan Tandukar | 125 | 15 | 97 | 21 | 14 | 330 |
All Works
Login with ORCID to disown or claim papers
Loading papers...